Drug Use Investigation of Kaletra Tablets (QD) on Patients With HIV-infection.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 10 Jun 2017 Biomarkers information updated
- 16 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Apr 2013 Planned end date changed from 1 Aug 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.